KDR is the principal receptor that promotes the proangiogenic action of vascular endothelial growth factor and is involved in the tumorigenesis and progression of many malignancies, including HCC (Zheng et al., 2014). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.